Literature DB >> 2008272

Clinical features of atopic keratoconjunctivitis.

S J Tuft1, D M Kemeny, J K Dart, R J Buckley.   

Abstract

The clinical spectrum of ocular disease in 37 patients with atopic keratoconjunctivitis (AKC) is described. Patients typically had a severe blepharoconjunctivitis. Associated corneal scarring, suppurative keratitis, or keratoconus were the major causes of visual loss. Serum and tear samples from these patients were analyzed to quantify total and specific IgE antibodies. The results were compared as a case control study with results from samples from 55 patients with other forms of atopic disease and 16 nonatopic volunteers. Although the mean values for total and specific IgEs in the serum of patients with atopic disease were markedly higher than the values from nonatopic controls (P less than 0.00002), a difference between the disease groups could not be demonstrated (P greater than 0.05). There were also differences between both the total IgE (P = 0.0002) and pollen-specific IgE (P = 0.015) in tears from patients with atopic disease and nonatopic controls, but not for house dust mite or cat dander-specific IgEs. These results suggest that clinical differences between groups of patients with chronic allergic external eye disease are not associated with specific patterns of IgE production.

Entities:  

Mesh:

Substances:

Year:  1991        PMID: 2008272     DOI: 10.1016/s0161-6420(91)32322-4

Source DB:  PubMed          Journal:  Ophthalmology        ISSN: 0161-6420            Impact factor:   12.079


  25 in total

Review 1.  Ocular mast cells. Characterization in normal and disease states.

Authors:  E B Cook; J L Stahl; N P Barney; F M Graziano
Journal:  Clin Rev Allergy Immunol       Date:  2001-04       Impact factor: 8.667

Review 2.  Allergic ocular disease. A review of pathophysiology and clinical presentations.

Authors:  L Bielory; P E Goodman; E M Fisher
Journal:  Clin Rev Allergy Immunol       Date:  2001-04       Impact factor: 8.667

3.  The clinical picture of vernal kerato-conjunctivitis in Uganda.

Authors:  M Kawuma
Journal:  Community Eye Health       Date:  2001

Review 4.  Allergic eye disease mechanisms.

Authors:  J I McGill; S T Holgate; M K Church; D F Anderson; A Bacon
Journal:  Br J Ophthalmol       Date:  1998-10       Impact factor: 4.638

5.  Therapeutic effect of 0.03% tacrolimus ointment for ocular graft versus host disease and vernal keratoconjunctivitis.

Authors:  Eun Hye Ryu; Joung Mok Kim; Pradnya M Laddha; Eui-Sang Chung; Tae-Young Chung
Journal:  Korean J Ophthalmol       Date:  2012-07-24

6.  Ocular Surface Squamous Neoplasia Associated with Atopic Keratoconjunctivitis.

Authors:  Ankit Shah; Edgar M Espana; Arun D Singh
Journal:  Ocul Oncol Pathol       Date:  2016-09-10

Review 7.  Topical ciclosporin in the treatment of ocular surface disorders.

Authors:  S Tatlipinar; E K Akpek
Journal:  Br J Ophthalmol       Date:  2005-10       Impact factor: 4.638

Review 8.  The ocular manifestations of atopic dermatitis and rosacea.

Authors:  Andrew S Eiseman
Journal:  Curr Allergy Asthma Rep       Date:  2006-07       Impact factor: 4.806

Review 9.  [Ocular allergies].

Authors:  E M Messmer
Journal:  Ophthalmologe       Date:  2005-05       Impact factor: 1.059

Review 10.  [Ocular involvement in atopic dermatitis : Clinical aspects and therapy].

Authors:  P Maier; T Lapp; T Reinhard
Journal:  Ophthalmologe       Date:  2017-06       Impact factor: 1.059

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.